Category: Coloplast
A federal judge denies Coloplast's motion to dismiss a personal injury lawsuit filed over the Virtue ventral urethral elevation sling.
Coloplast (CPH:COLO B) can't dodge a personal injury lawsuit filed in a Colorado federal court over its Virtue urethral sling, but the majority of the counts and moves for legal fees and punitive damages were stricken from the case.
Agilent Technologies pays $2.2 billion for Dako, a Denmark-based cancer diagnostics developer, marking the largest deal in Agilent history.
MASSDEVICE ON CALL — Agilent Technologies (NYSE:A) doled out more than $2 billion in cash to acquire Dako, a Denmark-based cancer diagnostic company with more than 1,000 employees with a foothold in more than 100 countries.
The deal, intended to grow Agilent's life sciences business, is the largest in the company's history, according to a press release.
Dr. Mark Midei, accused of implanting stents in hundreds of patients who didn't need them, lost a bid to reinstate his medical license back; also, Coloplast claims victory against Generic Medical Devices in patent spat and Cordis pursues subpoenas in stent lawsuit against Abbott.
Maryland denies accused over-stenter's bid to reclaim medical license
The list of the world's most ethical companies includes a few medical device makers and both of the top GPOs.
MASSDEVICE ON CALL — The 2012 list of the world's most ethical companies included a handful of medical device makers and group purchasing organizations, according to the research-based Ethisphere Institute.
The U.S. Attorney's office for Massachusetts drops its investigation of allegedly off-label marketing of Medtronic's biliary stents.
U.S. Attorney's office for Massachusetts dropped a years-long inquiry into allegations that Medtronic (NYSE:MDT) promoted off-label use for its biliary stents.
The Bay State feds told Medtronic Feb. 9 that the 3-year-old investigation is no longer active, according to a regulatory filing.
The probe began in June 2008, when the Fridley, Minn.-based med-tech company received a subpoena from the U.S. attorney's office for doucments and data related to possible off-label marketing of the stents.
Raytel Cardiac Services and Philips Remote Cardiac Services will cut 85 jobs in Connecticut next year.
MASSDEVICE ON CALL — Sister companies Raytel Cardiac Services Inc. and Philips Remote Cardiac Services plan to cut 85 jobs from a cardiac monitoring unit in Windsor, Conn.
The companies plan to cut work related to cardiac monitoring of pacemakers, but will keep 200 employees primarily focused on monitoring irregular heartbeats.
